{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:05:00Z","timestamp":1791309900320,"version":"4.3.1"},"reference-count":120,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI121180, R21AI109239, and R21AI128325"],"award-info":[{"award-number":["R01AI121180, R21AI109239, and R21AI128325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00436","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T07:16:30Z","timestamp":1492067790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies"],"prefix":"10.3389","volume":"8","author":[{"given":"Praneet","family":"Sandhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Humphries-Bickley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"issue":"Suppl","key":"B2","doi-asserted-by":"publisher","first-page":"S502","DOI":"10.1046\/j.1440-1746.17.s4.19.x","article-title":"The discovery of the hepatitis B virus and the invention of the vaccine: a scientific memoir","volume":"17","author":"Blumberg","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"B3","first-page":"651","article-title":"Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus","volume":"81","author":"Gerin","year":"1975","journal-title":"Am J Pathol"},{"issue":"4298","key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1126\/science.325649","article-title":"Australia antigen and the biology of hepatitis B","volume":"197","author":"Blumberg","year":"1977","journal-title":"Science"},{"issue":"7","key":"B5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u201cnew\u201d antigen in leukemia sera","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"issue":"7649","key":"B6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0140-6736(70)90926-8","article-title":"Virus-like particles in serum of patients with Australia-antigen-associated hepatitis","volume":"1","author":"Dane","year":"1970","journal-title":"Lancet"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/jhep.1996.v24.pm0008707245","article-title":"Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo","volume":"24","author":"Walter","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"B8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00000441-197201000-00005","article-title":"Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen","volume":"263","author":"Barker","year":"1972","journal-title":"Am J Med Sci"},{"issue":"3","key":"B9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"5 Suppl","key":"B10","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"The virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"B11","first-page":"91","article-title":"Natural history of chronic hepatitis B \u2013 clinical implications","volume":"10","author":"McMahon","year":"2008","journal-title":"Medscape J Med"},{"issue":"6","key":"B12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/0002-9343(73)90257-X","article-title":"Viral hepatitis B in neonates and infants","volume":"55","author":"Schweitzer","year":"1973","journal-title":"Am J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"2","key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/cmi.2013.66","article-title":"HBV life cycle is restricted in mouse hepatocytes expressing human NTCP","volume":"11","author":"Li","year":"2014","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"B15","doi-asserted-by":"publisher","first-page":"e1000741","DOI":"10.1371\/journal.ppat.1000741","article-title":"Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket","volume":"6","author":"Schmitz","year":"2010","journal-title":"PLoS Pathog"},{"issue":"22","key":"B16","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J Virol"},{"issue":"9\u2013480","key":"B17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"47","author":"Seeger","year":"2015","journal-title":"Virology"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1128\/JVI.03545-14","article-title":"The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription","volume":"89","author":"Tan","year":"2015","journal-title":"J Virol"},{"issue":"7","key":"B19","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1128\/JVI.66.7.4073-4084.1992","article-title":"Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus","volume":"66","author":"Yuh","year":"1992","journal-title":"J Virol"},{"issue":"6","key":"B20","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.4049\/jimmunol.1300512","article-title":"Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication","volume":"191","author":"Lu","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"issue":"15","key":"B22","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1128\/JVI.78.15.7867-7873.2004","article-title":"Innate sensing of viruses by toll-like receptors","volume":"78","author":"Boehme","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"B23","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02760-14","article-title":"Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"B24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4049\/jimmunol.0903874","article-title":"The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein","volume":"185","author":"Wei","year":"2010","journal-title":"J Immunol"},{"issue":"7","key":"B25","doi-asserted-by":"publisher","first-page":"e1000986","DOI":"10.1371\/journal.ppat.1000986","article-title":"Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/sj.icb.7100009","article-title":"Immunopathogenesis of hepatitis B virus infection","volume":"85","author":"Chang","year":"2006","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection","volume":"5","author":"Schuch","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"B29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"B30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","article-title":"Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B","volume":"54","author":"Tjwa","year":"2011","journal-title":"J Hepatol"},{"issue":"7","key":"B31","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.2811","article-title":"Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity","volume":"18","author":"Zeissig","year":"2012","journal-title":"Nat Med"},{"issue":"7","key":"B32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1084\/jem.192.7.921","article-title":"Natural killer T cell activation inhibits hepatitis B virus replication in vivo","volume":"192","author":"Kakimi","year":"2000","journal-title":"J Exp Med"},{"issue":"8","key":"B33","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/infdis\/jiu599","article-title":"Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function","volume":"211","author":"Boltjes","year":"2015","journal-title":"J Infect Dis"},{"issue":"6","key":"B34","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"H\u00f6sel","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"B35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.dld.2011.11.005","article-title":"Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta1 over pro-inflammatory cytokines","volume":"44","author":"Li","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"1","key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1084\/jem.20022235","article-title":"PD-1 inhibits antiviral immunity at the effector phase in the liver","volume":"198","author":"Iwai","year":"2003","journal-title":"J Exp Med"},{"issue":"3","key":"B37","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/hep.20366","article-title":"Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B","volume":"40","author":"van der Molen","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"B38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hep.21340","article-title":"Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV","volume":"44","author":"van der Molen","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"B39","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.4049\/jimmunol.178.10.6634","article-title":"B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B","volume":"178","author":"Chen","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"B40","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J Immunol"},{"issue":"5415","key":"B41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"issue":"19","key":"B42","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"B43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"issue":"8","key":"B44","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"issue":"3","key":"B45","doi-asserted-by":"publisher","first-page":"684.e","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"issue":"Pt 6","key":"B46","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","article-title":"The immune response during hepatitis B virus infection","volume":"87","author":"Bertoletti","year":"2006","journal-title":"J Gen Virol"},{"issue":"15","key":"B47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"Szmuness","year":"1980","journal-title":"N Engl J Med"},{"issue":"14","key":"B48","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"B49","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"issue":"4 Pt 1","key":"B50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"B51","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1128\/JVI.01902-08","article-title":"A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection","volume":"83","author":"Frelin","year":"2009","journal-title":"J Virol"},{"issue":"4","key":"B52","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molimm.2007.07.038","article-title":"PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients","volume":"45","author":"Peng","year":"2008","journal-title":"Mol Immunol"},{"issue":"5","key":"B53","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"B54","doi-asserted-by":"publisher","first-page":"e1003208","DOI":"10.1371\/journal.ppat.1003208","article-title":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells","volume":"9","author":"Schurich","year":"2013","journal-title":"PLoS Pathog"},{"issue":"6","key":"B55","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"B56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/j.1460-2075.1987.tb04807.x","article-title":"Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line","volume":"6","author":"Chang","year":"1987","journal-title":"EMBO J"},{"issue":"4","key":"B57","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"B58","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"B59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem Biol Interact"},{"issue":"1","key":"B60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J Gen Virol"},{"issue":"8","key":"B61","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"B62","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0168-8278(03)00120-X","article-title":"Primary human hepatocytes \u2013 a valuable tool for investigation of apoptosis and hepatitis B virus infection","volume":"38","author":"Schulze-Bergkamen","year":"2003","journal-title":"J Hepatol"},{"issue":"22","key":"B63","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.1128\/JVI.02073-13","article-title":"HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations","volume":"87","author":"Zhang","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"B64","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021469","article-title":"The chimpanzee model for hepatitis B virus infection","volume":"5","author":"Wieland","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"B65","first-page":"131","article-title":"The pathology of viral hepatitis types A and B in chimpanzees. A comparison","volume":"85","author":"Dienstag","year":"1976","journal-title":"Am J Pathol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1743-422X-9-170","article-title":"Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans","volume":"9","author":"Wang","year":"2012","journal-title":"Virol J"},{"issue":"11","key":"B67","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1128\/JVI.75.11.5084-5089.2001","article-title":"Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus","volume":"75","author":"K\u00f6ck","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"B68","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/j.1745-7254.2007.00641.x","article-title":"Antiviral effects of PNA in duck hepatitis B virus infection model","volume":"28","author":"Chen","year":"2007","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"B69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ilar.42.2.89","article-title":"The woodchuck model of hepatitis B virus infection","volume":"42","author":"Tennant","year":"2001","journal-title":"ILAR J"},{"issue":"12","key":"B70","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1128\/JVI.71.12.9392-9399.1997","article-title":"Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus","volume":"71","author":"Moraleda","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"B71","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/0042-6822(89)90199-2","article-title":"Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide","volume":"172","author":"Pugh","year":"1989","journal-title":"Virology"},{"issue":"12","key":"B72","doi-asserted-by":"publisher","first-page":"e0145465","DOI":"10.1371\/journal.pone.0145465","article-title":"Virus cccDNA amplification efficiency in natural infection is regulated by virus secretion efficiency","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"B73","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1073\/pnas.81.3.898","article-title":"Liver disease associated with duck hepatitis B virus infection of domestic ducks","volume":"81","author":"Marion","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"B74","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/030098588502200407","article-title":"Chronic hepatitis and hepatocellular carcinoma associated with persistent woodchuck hepatitis virus infection","volume":"22","author":"Roth","year":"1985","journal-title":"Vet Pathol"},{"issue":"2\u20133","key":"B75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0145-305X(99)00079-8","article-title":"Immune responses to duck hepatitis B virus infection","volume":"24","author":"Jilbert","year":"2000","journal-title":"Dev Comp Immunol"},{"issue":"1","key":"B76","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1128\/JVI.01263-15","article-title":"Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes","volume":"90","author":"Cui","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"B77","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/pathogens3020377","article-title":"Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions","volume":"3","author":"Inuzuka","year":"2014","journal-title":"Pathogens"},{"issue":"5","key":"B78","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2613.1998.740406.x","article-title":"Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection","volume":"79","author":"Akbar","year":"1998","journal-title":"Int J Exp Pathol"},{"issue":"4730","key":"B79","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.3865369","article-title":"A transgenic mouse model of the chronic hepatitis B surface antigen carrier state","volume":"230","author":"Chisari","year":"1985","journal-title":"Science"},{"issue":"8","key":"B80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/11347","article-title":"Hepatitis B virus transgenic mouse model of chronic liver disease","volume":"5","author":"Larkin","year":"1999","journal-title":"Nat Med"},{"issue":"47","key":"B81","doi-asserted-by":"publisher","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"B82","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"B83","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"B84","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"B85","doi-asserted-by":"publisher","first-page":"e1004032","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"issue":"2","key":"B86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"B87","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group","volume":"27","author":"Allen","year":"1998","journal-title":"Hepatology"},{"issue":"9","key":"B88","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"B89","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang","year":"2006","journal-title":"N Engl J Med"},{"issue":"17","key":"B90","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJMoa051214","article-title":"Variant of hepatitis B virus with primary resistance to adefovir","volume":"354","author":"Schildgen","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"B91","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":"Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion","volume":"32","author":"Tanji","year":"2001","journal-title":"Hum Pathol"},{"issue":"5","key":"B92","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy","volume":"49","author":"Tenney","year":"2009","journal-title":"Hepatology"},{"issue":"23","key":"B93","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"B94","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"B95","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/hep.20128","article-title":"Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B","volume":"39","author":"van Zonneveld","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"B96","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/0016-5085(93)90281-G","article-title":"Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B","volume":"104","author":"Hoofnagle","year":"1993","journal-title":"Gastroenterology"},{"issue":"4","key":"B97","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/JVI.64.4.1821-1824.1990","article-title":"Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription","volume":"64","author":"Tur-Kaspa","year":"1990","journal-title":"J Virol"},{"issue":"10","key":"B98","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJM197609022951001","article-title":"Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis","volume":"295","author":"Greenberg","year":"1976","journal-title":"N Engl J Med"},{"issue":"6176","key":"B99","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"issue":"4","key":"B100","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1365-2893.2003.00450.x","article-title":"Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"10","author":"Cooksley","year":"2003","journal-title":"J Viral Hepat"},{"issue":"7","key":"B101","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"B102","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the toll-like receptor 7 agonist GS-9620 in the woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"B103","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection","volume":"63","author":"Gane","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"B104","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/gutjnl-2013-305707","article-title":"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial \u2013 ANRS HB02 VAC-ADN","volume":"64","author":"Fontaine","year":"2015","journal-title":"Gut"},{"issue":"4","key":"B105","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3181\/00379727-151-39288","article-title":"Development and chimpanzee testing of a vaccine against human hepatitis B","volume":"151","author":"Buynak","year":"1976","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"B106","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/hep.20408","article-title":"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers","volume":"40","author":"Mancini-Bourgine","year":"2004","journal-title":"Hepatology"},{"issue":"7","key":"B107","doi-asserted-by":"publisher","first-page":"e2565","DOI":"10.1371\/journal.pone.0002565","article-title":"A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients","volume":"3","author":"Xu","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"B108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jcv.2004.07.004","article-title":"In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B","volume":"32","author":"Horiike","year":"2005","journal-title":"J Clin Virol"},{"issue":"2","key":"B109","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.0913498107","article-title":"Immune effectors required for hepatitis B virus clearance","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"B110","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J Hepatol"},{"issue":"5608","key":"B111","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"issue":"47","key":"B112","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"B113","doi-asserted-by":"publisher","first-page":"e1003613","DOI":"10.1371\/journal.ppat.1003613","article-title":"Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes","volume":"9","author":"Liu","year":"2013","journal-title":"PLoS Pathog"},{"issue":"42","key":"B114","doi-asserted-by":"publisher","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"issue":"49","key":"B116","doi-asserted-by":"publisher","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"B117","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1128\/AAC.00473-12","article-title":"Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation","volume":"56","author":"Cai","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"B118","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jhep.2010.10.025","article-title":"Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines","volume":"55","author":"Gehring","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"B119","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"B120","doi-asserted-by":"publisher","first-page":"e39179","DOI":"10.1371\/journal.pone.0039179","article-title":"PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model","volume":"7","author":"Tzeng","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T03:40:23Z","timestamp":1692762023000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":120,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00436","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}